Microproteins Skincare Global Market Report 2025

The microprotein skincare market size has grown strongly in recent years. It will grow from $3.04 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. Growth during the historic period can be attributed to increasing awareness of skincare benefits, rising demand for anti-aging products, growing interest in natural and protein-based ingredients, the expansion of personal care retail outlets, and higher disposable income.

The microprotein skincare market size is expected to see strong growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. Growth in the forecast period can be attributed to wider adoption of advanced peptide technologies, rising preference for bioactive skincare formulations, increased e-commerce penetration for skincare products, growing investment in premium skincare, and a more health-conscious consumer base. Major trends expected in the forecast period include technological advancements in peptide delivery systems, developments in nano-encapsulation techniques, increased research and development of bioactive formulations, innovations in sustainable and eco-friendly packaging, and progress in personalized skincare solutions.

The rising incidence of skin conditions is expected to drive the growth of the microprotein skincare market in the coming years. Skin conditions are disorders or abnormalities affecting the structure, appearance, or function of the skin, including acne, eczema, psoriasis, and infections. The prevalence of skin conditions is increasing as more consumers and healthcare professionals recognize the impact of environmental, lifestyle, and genetic factors on skin health and prioritize targeted solutions to manage and prevent these conditions. Microprotein skincare products contribute to skin health by promoting regeneration, repairing damaged tissues, enhancing barrier function, and reducing inflammation to restore overall skin condition. For example, in March 2025, according to the Chronic Skin Conditions statistics report published by the British Dermatological Nursing Group, a UK-based independent professional organization, melanoma cases in Northern Ireland are projected to rise by 28 percent by 2040, potentially adding an estimated $4.8 million (£3.8 million) in annual healthcare costs. Consequently, the rising incidence of skin conditions is fueling growth in the microprotein skincare market.

Leading companies in the microprotein skincare market are focusing on technological innovations, such as proprietary micropeptide technology, to enhance skin regeneration, improve collagen synthesis, and deliver targeted anti-aging benefits. Proprietary micro-peptide technology is a unique, company-developed process that creates bioactive micro-peptides designed to penetrate the skin deeply and stimulate natural regeneration, collagen production, and repair mechanisms for improved skincare effectiveness. For instance, in August 2024, Kenvue Inc., a US-based consumer health company, launched the Neutrogena Collagen Bank skincare line featuring patented micro-peptide technology that is twice as small as conventional peptides, enabling penetration through more than 10 layers of skin to strengthen existing collagen and stimulate new collagen production, thereby targeting early signs of skin aging. The line includes moisturizers for daily use, such as a broad-spectrum SPF 30 moisturizer and a product infused with bakuchiol, a plant-based retinol alternative, aimed primarily at Gen Z consumers who seek to prevent collagen loss and maintain youthful skin from their early 20s.

In June 2025, L'Oréal S.A., a France-based provider of skincare brands, acquired Medik8 for $1.32 billion. Through this acquisition, L’Oréal aims to strengthen its presence in the premium skincare segment by integrating Medik8’s expertise in scientifically advanced, in-house developed formulations, including high-performance serums and anti-aging creams, enhancing its portfolio of dermatologically driven and results-oriented skincare products. Medik8 is a UK-based provider of science-backed serums and anti-aging creams and offers microprotein skincare products.

Major companies operating in the microproteins skincare market are BASF SE, Kenvue Inc., Natura Bissé International S.A., Croda International Plc, Indeed Laboratories Inc., Geltor Inc., HydroPeptide LLC, BeautyStat Inc., Numaferm GmbH, AnteAGE Inc., CLR Chemisches Laboratorium, Erasa Skincare LLC, Intoxicated Cosmetics LLC, Kiwla Co. Ltd., Loti Labs LLC, Merz Pharma GmbH & Co. KGaA, OneSkin Inc., Peach and Lily Inc., Skin Actives Scientific LLC, Topaz Biosciences Inc.

Asia-Pacific was the largest region in the microproteins skincare market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in microprotein skincare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the microprotein skincare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The microproteins skincare market research report is one of a series of new reports that provides microproteins skincare market statistics, including microproteins skincare industry global market size, regional shares, competitors with a microproteins skincare market share, detailed microproteins skincare market segments, market trends and opportunities, and any further data you may need to thrive in the microproteins skincare industry. This microprotein skincare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Microprotein skincare refers to advanced formulations that incorporate small bioactive protein molecules capable of penetrating deep into the skin to support cellular regeneration and repair. These microproteins help stimulate collagen and elastin production, enhancing skin firmness, elasticity, and hydration while reducing wrinkles and other visible signs of aging for a more youthful appearance.

The main product types in microprotein skincare include creams, serums, masks, and lotions. Creams are thick, semi-solid formulations composed of a blend of water and oil. These products are distributed through both online and offline channels and are used for various applications, such as anti-aging, moisturizing, acne treatment, and care for sensitive skin.

The microprotein skincare market consists of sales of peptide boosters, protein-enriched serums, micropeptide creams, nano-protein masks, and bioactive protein oils. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.